IO Biotech today reported financial results for the second quarter ended June 30, 2024. Read more: https://bit.ly/3AnOcCy #IOBiotech #cancer #financialresults
IO Biotech’s Post
More Relevant Posts
-
Did you know that there are over 75 abstracts presenting data on antibody-drug conjugates (#ADCs) at #ESMO24? ADCs offer one possible way to kill #cancer cells. Learn more of the ABCs of ADCs below in 1 minute. ⬇ [Video description: An AbbVie scientist in the lab explains ADCs. On-screen text reads, "One Minute Thesis, ADCs (Antibody-Drug Conjugates)."]
To view or add a comment, sign in
-
"Hello friends, I am inviting you to submit your work for a special issue titled "Cancer Drug Discovery from Synthetic and Natural Sources." I am the editor of this issue and I am looking forward to seeing your original work in this special issue. #medicinalchemistry #organicsyntheis #cancer #drugdiscovery #syntheticchemisty #chemist https://lnkd.in/gWXXPtWB
To view or add a comment, sign in
-
-
The comprehensive nature of iPSirius's therapeutic product, IPVAC1.0, is explained in this newly posted introductory video. Enjoy! More detail at iPSirius.com #iPSC #cancer #advancedtherapies #cancertreatment #cgt #investinbiotech
To view or add a comment, sign in
-
LAST CHANCE! The Evolving Landscape of Cell Therapies Beyond CAR-T In this GEN Keynote webinar TODAY, our experts will discuss emerging cell therapies other than CAR-T. They share examples from their own work including recent advances in the development of NK-based cell therapies for cancers like multiple myeloma and sarcoma. Register now to join us for this free webinar sponsored by QIAGEN: https://ow.ly/rBHl50Sg91j #Cancer #Omics #TranslationalMedicine #DrugDiscovery Mark Frohlich Adrian Woolfson Parameswaran Hari
To view or add a comment, sign in
-
-
Bioss has a wide range of cancer-related antibodies specifically designed to target and detect various biomarkers. View our collection of cancer-related antibodies here: https://hubs.ly/Q02wyjw40 #Cancer #Research #CancerResearch #Antibodies #LifeScience #WesternBlot #ICC #IHC #FlowCytometry #ELISA #Immunofluorescence
To view or add a comment, sign in
-
OncoInfluencers to Follow on Social Media: Dr. Chris Boshoff, MD, PhD, FMedSci https://lnkd.in/dqzzsmjm #Cancer #CancerBiology #CancerResearch #OncoDaily #OncoInfluencers #Oncology #Pfizer #Research
To view or add a comment, sign in
-
-
Scientist and Bioinformatician Specializing in Molecular Genetics, Machine Learning, and Single Cell Analysis
Data that shows a linear trend are likely to have a strong association with PCs. Therefore, when you use PCA, the interpretation of the data is going to be highly accurate. For example, here in these plots, I separated ER+ and ER- breast cancer samples without labeling the data. However, if PCA fails in interpretation, then you need to find alternative methods which can give the best interpretation. #bioinformatics #PCA
To view or add a comment, sign in
-
-
Bioss has a wide range of cancer-related antibodies specifically designed to target and detect various biomarkers. View our collection of cancer-related antibodies here: https://hubs.ly/Q02nb5xt0 #Cancer #Research #CancerResearch #Antibodies #LifeScience #WesternBlot #ICC #IHC #FlowCytometry #ELISA #Immunofluorescence
To view or add a comment, sign in
-
🌟💬 Xtalks Spotlight: In this exclusive interview, Dr. Petra Dieterich, DPhil, MBA, Senior Vice President and Scientific Leader at Abzena, offers invaluable insights into the cutting-edge realm of Antibody-Drug Conjugates (ADCs) and their transformative impact on cancer treatment. ⏩ Watch the Spotlight video + read to delve into the intricacies of ADC development with expert insights on bioconjugate design by Dr. Petra Dieterich: https://buff.ly/46Bl3Qt #AntibodyDrugConjugates
To view or add a comment, sign in
-
🌟💬 Xtalks Spotlight: In this exclusive interview, Dr. Petra Dieterich, DPhil, MBA, Senior Vice President and Scientific Leader at Abzena, offers invaluable insights into the cutting-edge realm of Antibody-Drug Conjugates (ADCs) and their transformative impact on cancer treatment. ⏩ Watch the Spotlight video + read to delve into the intricacies of ADC development with expert insights on bioconjugate design by Dr. Petra Dieterich: https://buff.ly/46Bl3Qt #AntibodyDrugConjugates
To view or add a comment, sign in